IBD Digital revenue is up double digits as company adds multiple revenue channels designed around investors’ specific needs
Subscribers leverage IBD stock lists and premium investing products which consistently outperform the S&P by as much as three times
LOS ANGELES, Dec. 21, 2017 -- Investor’s Business Daily (IBD), a leading financial news and research organization, today announced a year of record growth across its entire portfolio of investing news, products, and educational services, all of which are designed to help consumers achieve their financial goals. By focusing solely on investors’ unique needs, IBD’s profits in 2017 are projected to more than double, which is a rare feat for any media company.
“IBD identified an important niche that was not adequately served, and we revamped our entire company to focus on providing the tools investors need to be successful. Our evolution has paid off,” said Jerry Ferrara, President of IBD. “Because of our strong subscriber engagement, advertisers continue to renew programs at near triple-digit levels. We are also seeing more prospective business partners come to us with hopes of striking new and innovative programs to complement their business initiatives.”
IBD established its strong position by relying on unbiased data to dictate market coverage and predictions, bucking the industry’s reliance on commentary or contributed content sponsored by public companies. As a result, IBD Digital subscriptions are up over 11 percent year-to-date despite an average subscription price that is approximately three times that of its competitors.
Digital subscribers are particularly reliant upon IBD’s stock lists as investment guides. Many stock lists, including IBD 50, IBD Sector Leaders, Leaderboard, and IBD Big Cap 20, consistently outperform the S&P by as much as three times, which is particularly remarkable given S&P’s outstanding returns in 2017. All of IBD’s lists are based on its proprietary CAN SLIM Investing System, which applies tried-and-true principles and insights to the market.
In fact, the lists have proven to perform so well that Innovator Capital Management has created two ETFs based on them. The Innovator IBD 50 ETF (Ticker:FFTY) was developed around IBD’s flagship index of leading growth stocks while the new IBD ETF Leaders ETF (Ticker:LDRS) has been designed for individual investors and robo advisors over the long-term.
The strategic integration of video has also helped IBD flourish in its transition to a modern media company. Monthly video streams are up six times year-over-year. They are also driving subscription conversion at a rate that is comparable to, and in some cases exceeds, conversion from news stories. Interestingly, because IBD’s revenue comes primarily from paid subscriptions, unlike the majority of the industry, video content can be tailored to what is most helpful to investors. The user experience is not impeded by irrelevant ads nor is content subject to advertiser influence.
IBD’s invaluable lists, videos, and numerous premium features are also available to subscribers via mobile apps, including IBD’s flagship app and the popular MarketSmith apps.
Additionally, the company developed a new revenue stream by offering personalized investor-focused educational opportunities such as webinars and live seminars. By placing an emphasis on quality, IBD has attracted large, engaged audiences of individual investors and professionals alike. For example, IBD produces among the largest and best attended webinars in the financial industry. These monthly webinars typically draw between 4,000-6,000 registrants.
To experience all that IBD has to offer and understand why the company has attracted such a prized audience of high net worth subscribers and customers, please visit www.investors.com.
About IBD
Investor's Business Daily (IBD) is a leading financial news and research organization recognized for proprietary stock screens, comparative performance ratings and a record of identifying stock leaders as they emerge. The company takes a data-first approach to investing, educating investors about how to invest successfully using tested methods and sound research. IBD has honed its approach over the last 50 years to help investors make smarter decisions. Its stock lists have outperformed the S&P, and its recent presidential poll, the most accurate over the past four election cycles, was one of only two national polls to accurately predict the outcome of the 2016 Presidential Election. IBD offers a number of interactive stock research tools and information for investors of every level. To learn more about all that IBD has available, please visit www.investors.com.
© 2017 Investor's Business Daily, Inc. All rights reserved. Investor's Business Daily, IBD, CAN SLIM and their corresponding logos are registered trademarks of Investor's Business Daily, Inc.
For Editorial Contact:
Marisa Lam
GMK Communications for IBD
[email protected]
650.544.3350


Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed 



